Nitric oxide, oxygen, and prostacyclin in children with pulmonary hypertension

Heart

Volumn 79, Issue 2, 1998, Pages 169-174

  Turanlahti, M I ^a   Laitinen, P O ^a   Sarna, S J ^a   Pesonen, E ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Children; Congenital heart disease; Nitric oxide; Prostacyclin; Pulmonary hypertension

Indexed keywords

NITRIC OXIDE; PROSTACYCLIN; VASODILATOR AGENT;

ADOLESCENT; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONGENITAL HEART DISEASE; DRUG EFFECT; FEMALE; HEMODYNAMIC PARAMETERS; HUMAN; INFANT; INTRAVENOUS DRUG ADMINISTRATION; LUNG BLOOD FLOW; LUNG CIRCULATION; MALE; OXYGEN THERAPY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; VASODILATATION;

EID: 0031892894     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.79.2.169     Document Type: Article

References (29)

1. Hopkins RA, Bull C, Haworth SG, et al. Pulmonary hypertensive crisis following surgery for congenital heart defects in young children. Eur J Cardiothorac Surg 1991;5:628-34.
2. Houde C, Bonn DJ, Freedom RM, et al. Profile of paediatric patients with pulmonary hypertension judged by responsiveness to vasodilators. Br Heart J 1993;70:461-8.
3. Bush A, Busst C, Booth K, et al. Does prostacyclin enhance the selective pulmonary vasodilator effect of oxygen in children with congenital heart disease? Circulation 1986;74: 135 44.
4. Pepke-Zaha J, Higenbottam T, Dinh-Xuan A. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet 1991;338:1173-4.
5. Haydar A, Mauriat P, Pouard P, et al. Inhaled nitric oxide for postoperative pulmonary hypertension in patients with congenital heart defects. Lancet 1992;340:1545.
6. Roberts JD Jr, Polaner DM, Lang P, et al. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1902;340:818-19.
7. Kinsella JP, Neish SR, Shaffer E, et al. Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992;340:819-20.
8. Frostell C, Fratacci M-D, Wain JC, et al. Inhaled nitric oxide-a selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 1991;83:2038-46.
9. Fratacci M-D, Frostell C, Chen T, et al. Inhaled nitric oxide - a selective pulmonary vasodilator of heparin-protamine vasoconstriction in sheep. Anesthesiology 1991; 75:990 9.
10. Berner M, Beghetti M, Ricou B, et al. Relief of severe pulmonary hypertension after closure of a large ventricular septal defect using low dose inhaled nitric oxide. Intensive Care Med 1993;19:75 7.
11. Frostell CG, Blomqvist H, Hedenstierna G, et al. Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilatation. Anesthesiology 1993;78:413 16.
12. Girard C, Lehot J-J, Pannetier J-C, et al. Inhaled nitric oxide after mitral valve replacement in patients with chronic pulmonary artery hypertension. Anesthesiology 1992;77:880 3.
13. Adatia I, Perry S, Landzberg M, et al. Inhaled nitric oxide and bemodynamic evaluation of patients with pulmonary hypertension before transplantation. J Am Coll Cardiol 1995;25:1656-64.
14. Beghetti M, Habre W, Friedli B, et al. Continuous low dose inhaled nitric oxide for treatment of severe pulmonary hypertension after cardiac surgery in paediatric patients. Br Heart J 1995;73:65-8.
15. Berner M, Beghetti M, Spahr-Schopfer I, et al. Inhaled nitric oxide to test the vasodilator capacity of the pulmonary vascular bed in children with long-standing pulmonary hypertension and congenital heart disease. Am J Cardiol 1996;77:532 5.
16. Pearl RG. Inhaled nitric oxide: the past, the present and the future. Anesthesiology 1993;78:413 16.
17. Winherg P, Lundell BPW, Gustafsson LE. Effect of inhaled nitric oxide on raised pulmonary vascular resistance in children with congenital heart disease. Br Heart J 1994;71: 282 6.
18. Chiodi H, Mohler JG. Effects of exposure of blood hemoglobin to nitric oxide. Environ Res 1985;37:355-63.
19. Celermajer DS, Cullen S, Deanfield JE. Impairment of endothelium-dependent pulmonary artery relaxation in children with congenital heart disease and abnormal pulmonary hemodynamics. Circulation 1993;87:440-6.
20. Dinh-Xuan AT, Higenbottam TW, Clelland C, et al. Impairment of pulmonary endothelium-dependent relaxation in patients with Eisenmenger's syndrome. Br J Pharmacol 1989;99:9-10.
21. Miller OI, Celermajer DS, Deanheld JE, et al. Very-low-dose inhaled nitric oxide: a selective pulmonary vasodilator after operations for congenital heart disease. J Thorac Cardiovasc Surg 1994;108:487-94.
22. Roberts JD Jr, Lang P, Bigatello LM, et al. Inhaled nitric oxide in congenital heart disease. Circulation 1993;87:447 53.
23. Bigatello LM, Hurford WE, Kacmarek RM, et al. Prolonged administration of low concentrations of nitric oxide in patients with severe adult respiratory distress syndrome. Anesthesiology 1994;80:761 70.
24. Kieler-Jensen N, Ricksten SE, Stenqvist O, et al. Inhaled nitric oxide in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance. J Heart Lung Transplant 1994;13:366-75.
25. Goldman AP, Delius RE, Deanfield JE, et al. Nitric oxide is superior to prostacyclm for pulmonary hypertension after cardiac operations. Ann Thorac Surg 1995;60:300 5.
26. Adatia I, Wessel DL. Therapeutic use of inhaled nitric oxide. Curr Opin Pediatr 1994;6:583 90.
27. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:110-42.
28. Miller OI, Celermajer DS, Deanfield JE, et al. Guidelines for the safe administration of inhaled nitric oxide. Arch Dis Child 1994;70:F47 9.
29. Foubert L, Fleming B, Latimer R, et al. Safety guidelines for use of nitric oxide. Lancet 1992;339:1615 16.